企業プロフィール
Protagenic Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- PTIX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.36 USD (0.00%)
終値
最終更新: 2026年8月14日
—
時価総額
株価変動の要因
Current closing-price context is not available for PTIX.
企業概要
事業概要
Protagenic Therapeutics is a biotechnology company focused on neuropsychiatric and stress-related disorders. Its story is built around the idea that peptide-based or related approaches can address difficult CNS conditions.
所在地とセクター分類
Protagenic is headquartered in the United States and listed on NASDAQ. It sits in small-cap neuroscience biotechnology.
ビジネスモデルの特徴
The company depends on preclinical and early clinical validation, translational credibility, and capital support. Investors typically watch early data, pipeline prioritization, and whether the company can narrow its story into a viable CNS thesis.
バイオ業界での位置付け
Protagenic occupies a speculative neuroscience niche within biotech. It is a high-risk story where platform proof matters more than near-term commercial scale.
今後のカタリスト
- Protagenic’s catalysts are neuropeptide and CNS programs, with any update that clarifies whether the company can still produce meaningful development progress. The stock needs a cleaner clinical path.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。